Advisory Services Network’s West Pharmaceutical WST Stock Holding History

Advisory Services Network’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.2K	Buy	+69	New	+$17.2K	﹤0.01%	3284
2025 Q4	–	Sell	-42	Closed	-$10.9K	–	4247
2025 Q3	$10.9K	Buy	+42	New	+$10.2K	﹤0.01%	3249
2024 Q1	–	Sell	-95	Closed	-$33.3K	–	3665
2023 Q4	$33.3K	Buy	+95	New	+$33.6K	﹤0.01%	2243
2023 Q2	–	Sell	-150	Closed	-$52K	–	3666
2023 Q1	$52K	Sell	150 -13	-8%	-$3.8K	﹤0.01%	1997
2022 Q4	$38.4K	Buy	+163	New	+$38.6K	﹤0.01%	2114
2022 Q2	–	Sell	-1,307	Closed	-$537K	–	1520
2022 Q1	$537K	Sell	1,307 -292	-18%	-$114K	0.02%	882
2021 Q4	$750K	Buy	1,599 +389	+32%	+$167K	0.02%	730
2021 Q3	$514K	Buy	1,210 +309	+34%	+$130K	0.02%	862
2021 Q2	$324K	Buy	+901	New	+$298K	0.01%	1051
2021 Q1	–	Sell	-233	Closed	-$66K	–	2958
2020 Q4	$66K	Sell	233 -189	-45%	-$53K	﹤0.01%	1536
2020 Q3	$116K	Buy	+422	New	+$112K	0.01%	1189
2020 Q2	–	Sell	-333	Closed	-$51K	–	2749
2020 Q1	$51K	Sell	333 -47	-12%	-$7.23K	﹤0.01%	1382
2019 Q4	$58K	Sell	380 -13	-3%	-$1.89K	﹤0.01%	1424
2019 Q3	$49K	Hold	393	–	–	﹤0.01%	1376
2019 Q2	$49K	Buy	393 +180	+85%	+$21.2K	﹤0.01%	1374
2019 Q1	$24K	Sell	213 -51	-19%	-$5.3K	﹤0.01%	1545
2018 Q4	$26K	Buy	264 +94	+55%	+$10.2K	﹤0.01%	1393
2018 Q3	$21K	Buy	170 +16	+10%	+$1.79K	﹤0.01%	1559
2018 Q2	$17K	Hold	154	–	–	﹤0.01%	1611
2018 Q1	$14K	Buy	154 +55	+56%	+$5.14K	﹤0.01%	1779
2017 Q4	$10K	Buy	99 +51	+106%	+$5K	﹤0.01%	1847
2017 Q3	$5K	Hold	48	–	–	﹤0.01%	1914
2017 Q2	$5K	Hold	48	–	–	﹤0.01%	1842
2017 Q1	$4K	Buy	+48	New	+$4.01K	﹤0.01%	1829
2016 Q3	$4K	Sell	48 -78	-62%	-$6.19K	﹤0.01%	1622
2016 Q2	$10K	Buy	126 +48	+62%	+$3.49K	﹤0.01%	1214
2016 Q1	$5K	Hold	78	–	–	﹤0.01%	1285
2015 Q4	$5K	Hold	78	–	–	﹤0.01%	1159
2015 Q3	$4K	Sell	78 -21	-21%	-$1.22K	﹤0.01%	1201
2015 Q2	$6K	Hold	99	–	–	﹤0.01%	1041
2015 Q1	$6K	Sell	99 -41	-29%	-$2.19K	﹤0.01%	969
2014 Q4	$7K	Buy	+140	New	+$7K	﹤0.01%	827
2014 Q1	–	Sell	-114	Closed	-$6K	–	813
2013 Q4	$6K	Buy	+114	New	+$5.33K	﹤0.01%	754

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advisory Services Network's WST Position: Q1 2026 in Review

Advisory Services Network opened a new position in West Pharmaceutical (WST) in Q1 2026: 69 shares worth $17.2K. The stake represents ﹤0.01% of the portfolio and ranks #3284 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in WST as recently as Q3 2025.

Advisory Services Network first reported a position in WST in Q4 2013 and has held it in 33 quarters since. The position peaked at $750K in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Advisory Services Network held 69 shares of West Pharmaceutical worth $17.2K as of Q1 2026.
West Pharmaceutical was a new Advisory Services Network position in Q1 2026.
West Pharmaceutical made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3284 holding.
Advisory Services Network first reported a position in West Pharmaceutical in Q4 2013 and has held it in 33 quarters since.
Advisory Services Network's West Pharmaceutical position peaked at $750K in Q4 2021.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.